The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria
Abstract
In recent years, because of increased resistance to conventional antimicrobials, many researchers have started to study the synthesis of new antibiotics to control the disease-causing effects of infectious pathogens. Antimicrobial peptides (AMPs) are among the newest antibiotics; these peptides are integral compounds in all kinds of organisms and play a significant role in microbial ecology, and critically contribute to the innate immunity of organisms by destroying invading microorganisms. Moreover, AMPs may encourage cells to produce chemokines, stimulate angiogenesis, accelerate wound healing, and influence programmed cell death in multicellular organisms. Bacteria differ in their inherent susceptibility and resistance mechanisms to these peptides when responding to the antimicrobial effects of AMPs. Generally, the development of AMP resistance mechanisms is driven by direct competition between bacterial species, and host and pathogen interactions. Several studies have shown diverse mechanisms of bacterial resistance to AMPs, for example, some bacteria produce proteases and trapping proteins; some modify cell surface charge, change membrane fluidity, and activate efflux pumps; and some species make use of biofilms and exopolymers, and develop sensing systems by selective gene expression. A closer understanding of bacterial resistance mechanisms may help in developing novel therapeutic approaches for the treatment of infections caused by pathogenic organisms that are successful in developing extensive resistance to AMPs. Based on these observations, this review discusses the properties of AMPs, their targeting mechanisms, and bacterial resistance mechanisms against AMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Sequence and specificity of two antibacterial proteins involved in insect immunity
Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981) · Nature · doi:10.1038/292246a0 · Cited by 1,427
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
HULTMARK, D., STEINER, H., RASMUSON, T., & BOMAN, H. G. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb05991.x · Cited by 1,008
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
APD: the Antimicrobial Peptide Database
Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit
Dias, A., Bouvier, D., Crépin, T., McCarthy, A. A., Hart, D. J., Baudin, F., Cusack, S., & Ruigrok, R. W. H. (2009) · Nature · doi:10.1038/nature07745 · Cited by 763
Dermcidin: A novel human antibiotic peptide secreted by sweat glands
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., Schroeder, K., Blin, N., Meier, F., et al. (2001) · Nature Immunology · doi:10.1038/ni732 · Cited by 730
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Antimicrobial peptides: The ancient arm of the human immune system
Wiesner, J., & Vilcinskas, A. (2010) · Virulence · doi:10.4161/viru.1.5.12983 · Cited by 684
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase
Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A. R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H., & Miller, S. I. (2005) · Cell · doi:10.1016/j.cell.2005.05.030 · Cited by 567
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Sato, H., & Feix, J. B. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.021 · Cited by 522
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site
Yuan, P., Bartlam, M., Lou, Z., Chen, S., Zhou, J., He, X., Lv, Z., Ge, R., Li, X., Deng, T., et al. (2009) · Nature · doi:10.1038/nature07720 · Cited by 497
Meena, K. R., & Kanwar, S. S. (2015) · BioMed Research International · doi:10.1155/2015/473050 · Cited by 474
Selsted, M. E., Tang, Y. Q., Morris, W. L., McGuire, P. A., Novotny, M. J., Smith, W., Henschen, A. H., & Cullor, J. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53298-1 · Cited by 443
Antimicrobial Peptides: Primeval Molecules or Future Drugs?
Peters, B. M., Shirtliff, M. E., & Jabra-Rizk, M. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001067 · Cited by 425
Antimicrobial Peptides Targeting Gram-Positive Bacteria
Malanovic, N., & Lohner, K. (2016) · Pharmaceuticals · doi:10.3390/ph9030059 · Cited by 420
The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P. E., & Sahl, H.-G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.154 · Cited by 381
Ernst, C. M., Staubitz, P., Mishra, N. N., Yang, S.-J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 368
Bacterial strategies of resistance to antimicrobial peptides
Joo, H.-S., Fu, C.-I., & Otto, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0292 · Cited by 360
Defensins from Insects and Plants Interact with Fungal Glucosylceramides
Thevissen, K., Warnecke, D. C., François, I. E. J. A., Leipelt, M., Heinz, E., Ott, C., Zähringer, U., Thomma, B. P. H. J., Ferket, K. K. A., & Cammue, B. P. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311165200 · Cited by 354
Sitaram, N., & Nagaraj, R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00199-6 · Cited by 353
Design of model amphipathic peptides having potent antimicrobial activities
Blondelle, S. E., & Houghten, R. A. (1992) · Biochemistry · doi:10.1021/bi00165a020 · Cited by 352
Small cationic antimicrobial peptides delocalize peripheral membrane proteins
Wenzel, M., Chiriac, A. I., Otto, A., Zweytick, D., May, C., Schumacher, C., Gust, R., Albada, H. B., Penkova, M., Krämer, U., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319900111 · Cited by 340
PHAGOCYTIN: A BACTERICIDAL SUBSTANCE FROM POLYMORPHONUCLEAR LEUCOCYTES
Hirsch, J. G. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.5.589 · Cited by 325
AVPpred: collection and prediction of highly effective antiviral peptides.
Thakur, N., Qureshi, A., & Kumar, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks450 · Cited by 324
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Mootz, H. D., & Marahiel, M. A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6843-6850.1997 · Cited by 300
Antimicrobial Peptides: Versatile Biological Properties
Pushpanathan, M., Gunasekaran, P., & Rajendhran, J. (2013) · International Journal of Peptides · doi:10.1155/2013/675391 · Cited by 292
Gram-positive three-component antimicrobial peptide-sensing system
Li, M., Lai, Y., Villaruz, A. E., Cha, D. J., Sturdevant, D. E., & Otto, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702159104 · Cited by 288
An overview of antimicrobial peptides and the latest advances in their development
Sierra, J. M., Fusté, E., Rabanal, F., Vinuesa, T., & Viñas, M. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1315402 · Cited by 283
The lantibiotic nisin, a special case or not?
Breukink, E., & de Kruijff, B. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00208-4 · Cited by 282
Antimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275
Properties and mechanisms of action of naturally occurring antifungal peptides
van der Weerden, N. L., Bleackley, M. R., & Anderson, M. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1260-1 · Cited by 271
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis
Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 249
Buforins: Histone H2A-derived antimicrobial peptides from toad stomach
Cho, J. H., Sung, B. H., & Kim, S. C. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.025 · Cited by 248
outer membrane remodeling: role in resistance to host innate immunity
Ernst, R. K., Guina, T., & Miller, S. I. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01494-0 · Cited by 238
Peptides and Peptidomimetics for Antimicrobial Drug Design
Mojsoska, B., & Jenssen, H. (2015) · Pharmaceuticals · doi:10.3390/ph8030366 · Cited by 229
Stumpe, S., Schmid, R., Stephens, D. L., Georgiou, G., & Bakker, E. P. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.15.4002-4006.1998 · Cited by 214
Auvynet, C., & Rosenstein, Y. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07360.x · Cited by 212
Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification
Zeya, H. I., & Spitznagel, J. K. (1963) · Science · doi:10.1126/science.142.3595.1085 · Cited by 210
Antimicrobial Peptides Under Clinical Trials
E. Greber, K., & Dawgul, M. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713143331 · Cited by 210
A new subfamily of bacterial ABC‐type transport systems catalyzing export of drugs and carbohydrates
Reizer, J., Reizer, A., & Saier, M. H. (1992) · Protein Science · doi:10.1002/pro.5560011012 · Cited by 207
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages.
Selsted, M. E., Brown, D. M., DeLange, R. J., & Lehrer, R. I. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43888-9 · Cited by 205
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria
Li, W., Tailhades, J., O’Brien-Simpson, N. M., Separovic, F., Otvos, L., Hossain, M. A., & Wade, J. D. (2014) · Amino Acids · doi:10.1007/s00726-014-1820-1 · Cited by 192
Bierbaum, G., & Sahl, H. G. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5452-5458.1987 · Cited by 191
Bacterial modification of LPS and resistance to antimicrobial peptides
Gunn, J. S. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070011001 · Cited by 191
Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes
Levy, O. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604320 · Cited by 191
Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides
Wang, G. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2285-7_3 · Cited by 187
On the selectivity and efficacy of defense peptides with respect to cancer cells
Harris, F., Dennison, S. R., Singh, J., & Phoenix, D. A. (2013) · Medicinal Research Reviews · doi:10.1002/med.20252 · Cited by 185
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria
Band, V., & Weiss, D. (2014) · Antibiotics · doi:10.3390/antibiotics4010018 · Cited by 185
Seefeldt, A. C., Nguyen, F., Antunes, S., Pérébaskine, N., Graf, M., Arenz, S., Inampudi, K. K., Douat, C., Guichard, G., Wilson, D. N., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3034 · Cited by 184
The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin
Roy, R. N., Lomakin, I. B., Gagnon, M. G., & Steitz, T. A. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3031 · Cited by 184
Hancock, R. E., Farmer, S. W., Li, Z. S., & Poole, K. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1309 · Cited by 180
Sakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Modulation of Magainin 2−Lipid Bilayer Interactions by Peptide Charge
Matsuzaki, K., Nakamura, A., Murase, O., Sugishita, K.-I., Fujii, N., & Miyajima, K. (1997) · Biochemistry · doi:10.1021/bi961870p · Cited by 167
Peptide-based antifungal therapies against emerging infections
Matejuk, A., Leng, Q., Begum, M., Woodle, M. C., Scaria, P. V., Chou, S.-T., & Mixson, A. J. (2010) · Drugs of the Future · doi:10.1358/dof.2010.035.03.1452077 · Cited by 167
Malik, E., Dennison, S. R., Harris, F., & Phoenix, D. A. (2016) · Pharmaceuticals · doi:10.3390/ph9040067 · Cited by 166
Bacterial resistance mechanisms against host defense peptides
Koprivnjak, T., & Peschel, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0716-4 · Cited by 164
Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions
Kacprzyk, L., Rydengård, V., Mörgelin, M., Davoudi, M., Pasupuleti, M., Malmsten, M., & Schmidtchen, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.06.020 · Cited by 163
Sperandio, B., Regnault, B., Guo, J., Zhang, Z., Stanley, S. L., Sansonetti, P. J., & Pédron, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071698 · Cited by 162
Leiter, E., Szappanos, H., Oberparleiter, C., Kaiserer, L., Csernoch, L., Pusztahelyi, T., Emri, T., Pócsi, I., Salvenmoser, W., & Marx, F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2445-2453.2005 · Cited by 159
Apidaecin-type peptides: Biodiversity, structure–function relationships and mode of action
Li, W., Ma, G.-X., & Zhou, X. (2006) · Peptides · doi:10.1016/j.peptides.2006.03.016 · Cited by 157
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria
Nawrocki, K. L., Crispell, E. K., & McBride, S. M. (2014) · Antibiotics · doi:10.3390/antibiotics3040461 · Cited by 157
Antimicrobial peptides and the skin immune defense system
Schauber, J., & Gallo, R. L. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.014 · Cited by 157
Perspective of Use of Antiviral Peptides against Influenza Virus
Skalíčková, S., Heger, Z., Krejčová, L., Pekařík, V., Bastl, K., Janda, J., Kostolanský, F., Varečková, E., Zítka, O., Adam, V., et al. (2015) · Viruses · doi:10.3390/v7102883 · Cited by 154
Lipoteichoic Acids, Phosphate-Containing Polymers in the Envelope of Gram-Positive Bacteria
Schneewind, O., & Missiakas, D. M. (2014) · Journal of Bacteriology · doi:10.1128/jb.01155-13 · Cited by 152
Echinocandins in antifungal pharmacotherapy
Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145
Castle, M., Nazarian, A., Yi, S. S., & Tempst, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32555 · Cited by 141
Farkas, A., Maróti, G., Kereszt, A., & Kondorosi, É. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00051 · Cited by 136
Antiviral cyclic d,l-α-peptides: Targeting a general biochemical pathway in virus infections
Horne, W. S., Wiethoff, C. M., Chunli, C., Wilcoxen, K., Amorín, M., Ghadiri, M. R., & Nemerow, G. R. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.051 · Cited by 129
Defensins and Other Antimicrobial Peptides: A Historical Perspective and an Update
Ganz, T. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764594 · Cited by 128
Bacterial resistance to cationic antimicrobial peptides
Anaya-López, J. L., López-Meza, J. E., & Ochoa‐Zarzosa, A. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.699025 · Cited by 127
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Genetic and Biochemical Analysis of Mutacin 1140, a Lantibiotic from Streptococcus mutans
Hillman, J. D., Novák, J., Sagura, E., Gutierrez, J. A., Brooks, T. A., Crowley, P. J., Hess, M. E., Azizi, A., Leung, K. ‐., Cvitkovitch, D. G., et al. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2743-2749.1998 · Cited by 118
Antimicrobial Peptide Action on Parasites
Torrent, M., Pulido, D., Rivas, L., & Andreu, D. (2012) · Current Drug Targets · doi:10.2174/138945012802002393 · Cited by 113
Jenssen, H., Andersen, J. H., Uhlin‐Hansen, L., Gutteberg, T. J., & Rekdal, Ø. (2003) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.001 · Cited by 100
Mandal, S. M., Sharma, S., Pinnaka, A. K., Kumari, A., & Korpole, S. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-152 · Cited by 99
Bacterial Sensing of Antimicrobial Peptides
Otto, M. J. (2009) · Contributions to microbiology · doi:10.1159/000219377 · Cited by 98
Jones, A., Geörg, M., Maudsdotter, L., & Jonsson, A. (2009) · Journal of Bacteriology · doi:10.1128/jb.01313-08 · Cited by 91
Weidenmaier, C., Kristian, S. A., & Peschel, A. (2003) · Current Drug Targets · doi:10.2174/1389450033490731 · Cited by 90
Samant, S., Hsu, F., Neyfakh, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.01345-08 · Cited by 86
Short Cationic Antimicrobial Peptides Interact with ATP
Hilpert, K., McLeod, B. N., Yu, J. Z., Elliott, M. R., Rautenbach, M., Ruden, S., Bürck, J., Muhle‐Goll, C., Ulrich, A. S., Keller, S., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-09 · Cited by 81
Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2
Pränting, M., Negrea, A., Rhen, M., & Andersson, D. I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00205-08 · Cited by 76
Suárez, J. M., Edwards, A. N., & McBride, S. M. (2013) · Journal of Bacteriology · doi:10.1128/jb.00166-13 · Cited by 74
Moghaddam, M. M., Barjini, K. A., Fasihi‐Ramandi, M., & Amani, J. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1575-y · Cited by 71
ATP Synthase: A Molecular Therapeutic Drug Target for Antimicrobial and Antitumor Peptides
Ahmad, Z., Okafor, F., Azim, S., & Laughlin, T. F. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320150003 · Cited by 70
Hirakura, Y., Kobayashi, S., & Matsuzaki, K. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00358-9 · Cited by 70
Mann, P. A., Müller, A., Xiao, L., Pereira, P. M., Yang, C., Lee, S. H., Wang, H., Trzeciak, J., Schneeweis, J. E., dos Santos, M. M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400487f · Cited by 69
A novel family of peptides with potent activity against influenza A viruses
Nicol, M. Q., Ligertwood, Y., Bacon, M. N., Dutia, B. M., & Nash, A. A. (2012) · Journal of General Virology · doi:10.1099/vir.0.038679-0 · Cited by 65
The secrets of dermcidin action
Burian, M., & Schittek, B. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.12.012 · Cited by 63
Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata
Ma, Y., Liu, C., Liu, X., Wu, J., Yang, H., Wang, Y., Li, J., Yu, H., & Lai, R. (2009) · Genomics · doi:10.1016/j.ygeno.2009.09.004 · Cited by 62
Moghaddam, M. M., Abolhassani, F., Babavalian, H., Mirnejad, R., Barjini, K. A., & Amani, J. (2012) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-012-9098-7 · Cited by 59
Self-citationLiu, Y., Gong, W., Huang, C. C., Herr, W., & Cheng, X. (1999) · Genes & Development · doi:10.1101/gad.13.13.1692 · Cited by 58
Active Internalization of the Penicillium chrysogenum Antifungal Protein PAF in Sensitive Aspergilli
Oberparleiter, C., Kaiserer, L., Haas, H., Ladurner, P., Andratsch, M., & Marx, F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3598-3601.2003 · Cited by 54
Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
Lacerda, A. F., Pelegrini, P. B., de Oliveira, D. M., de Vasconcelos, É. A. R., & Grossi‐de‐Sá, M. F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00091 · Cited by 54
Taniguchi, M., Ochiai, A., Kondo, H., Fukuda, S., Ishiyama, Y., Saitoh, E., Kato, T., & Tanaka, T. (2015) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2015.09.002 · Cited by 53
Stephan, A., Batinica, M., Steiger, J., Hartmann, P., Zaucke, F., Bloch, W., & Fabri, M. (2016) · Immunology · doi:10.1111/imm.12620 · Cited by 49
Vancomycin: Understanding Its Past and Preserving Its Future
Levine, D. P. (2008) · Southern Medical Journal · doi:10.1097/smj.0b013e3181647037 · Cited by 49
The development of antimicrobial peptides as an approach to prevention of antibiotic resistance
Moghaddam, M. M., Aghamollaei, H., Kooshki, H., Barjini, K. A., Mirnejad, R., & Choopani, A. (2015) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000032 · Cited by 48
Self-citationFrom Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Azad, Z. M., Moravej, H., Fasihi‐Ramandi, M., Masjedian, F., Nazari, R., Mirnejad, R., & Moghaddam, M. M. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000524 · Cited by 45
Self-citationAhmed, C. M. I., Dabelic, R., Waiboci, L. W., Jager, L. D., Heron, L. L., & Johnson, H. M. (2008) · Journal of Virology · doi:10.1128/jvi.01138-08 · Cited by 42
Antimicrobial peptides are signaling molecules
Salzet, M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02236-6 · Cited by 42
Chen, W., Zeng, H., & Tan, H. (2000) · Current Microbiology · doi:10.1007/s002840010141 · Cited by 41
The Capsule Sensitizes Streptococcus pneumoniae to α-Defensins Human Neutrophil Proteins 1 to 3
Beiter, K., Wartha, F., HURWITZ, R. M., Normark, S. J., Zychlinsky, A., & Henriques‐Normark, B. (2008) · Infection and Immunity · doi:10.1128/iai.01748-07 · Cited by 40
Anionic Antimicrobial Peptides from Eukaryotic Organisms and their Mechanisms of Action
Harris, F., Dennison, S. R., & Phoenix, D. A. (2011) · Current Chemical Biology · doi:10.2174/2212796811105020142 · Cited by 37
In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs
Schmidt, R., Knappe, D., Wende, E., Ostorházi, E., & Hoffmann, R. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00015 · Cited by 36
Al-Rayahi, I., & Sanyi, R. H. H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00002 · Cited by 34
Hoffmann, J., Schneider, C., Heinbockel, L., Brandenburg, K., Reimer, R., & Gabriel, G. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.01.015 · Cited by 33
Recombinant Lysostaphin Protects Mice from Methicillin-ResistantStaphylococcus aureusPneumonia
Chen, C., Fan, H., Huang, Y., Peng, F., Fan, H., Yuan, S., & Tong, Y. (2014) · BioMed Research International · doi:10.1155/2014/602185 · Cited by 18
New agents approved for treatment of acute staphylococcal skin infections
Tatarkiewicz, J., Staniszewska, A., & Bujalska‐Zadrożny, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59838 · Cited by 17
Cited by
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review
Sharun, K., Dhama, K., Tiwari, R., Gugjoo, M. B., Iqbal Yatoo, M., Patel, S. K., Pathak, M., Karthik, K., Khurana, S. K., Singh, R., et al. (2021) · Veterinary Quarterly · doi:10.1080/01652176.2021.1882713 · Cited by 359
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Metadata
- Authors
- Moravej, H., Moravej, Z., Yazdanparast, M., Heiat, M., Mirhosseini, A., Moosazadeh Moghaddam, M., & Mirnejad, R.
- Venue
- Microbial Drug Resistance
- Publisher
- SAGE Publications
- Published
- 2018-07
- Volume
- 24
- Issue
- 6
- Pages
- 747-767
- ISSN
- 1076-6294 (ISSN-L)
- 1931-8448
- OpenAlex
- W2809827657
- Cited by
- 410
- References
- 125
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.